Premium
BENEFITS AND RISKS OF INHALED CORTICOSTEROID TREATMENT IN PATIENTS WITH COPD CLASSIFIED BY BLOOD EOSINOPHIL COUNTS
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13419_199
Subject(s) - medicine , copd , eosinophil , corticosteroid , inhaled corticosteroids , immunology , asthma , intensive care medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom